Fig. 1: S1-reactive IgA and IgG antibody results. | Communications Medicine

Fig. 1: S1-reactive IgA and IgG antibody results.

From: Neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independently of symptoms in adults

Fig. 1

Presented as proportions of the total study population (n = 1655) (a), of those without (b) and with detectable S1-reactive antibodies (c) dependent whether symptoms were recorded, according to workplace (d). Antibodies were measured in sera from the initial blood draw at day 0. Columns represent percentages of the total study population at the first blood draw (b–d).

Back to article page